Press Releases AlzChem Group AG

Equities

ACT

DE000A2YNT30

Market Closed - Xetra Other stock markets 16:36:01 28/06/2024 BST			5-day change	1st Jan Change
48.4 ^EUR	-0.41%		+6.61%	+86.15%

04-30	Transcript : AlzChem Group AG, Q1 2024 Earnings Call, Apr 30, 2024
04-30	AlzChem Group AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06-13	EQ
Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06-12	EQ
Alzchem Group AG: Three Alzchem climate projects receive public funding of around EUR 850 thousand	06-07	EQ
AlzChem : Factsheet (20240607 Factsheet Alzchem EN)	06-07	PU
Alzchem Group AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	06-06	EQ
AlzChem : Eminex® - Research project and biogas	05-16	PU
Alzchem Group AG receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved	05-07	EQ
Alzchem : receives strong support from shareholders at Annual General Meeting; dividend increase to EUR 1.20 per share approved	05-07	PU
Alzchem Group AG seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024	04-30	EQ
AlzChem : Quarterly Statement Q1 2024	04-30	PU
AlzChem : Corporate News Q1 2024	04-30	PU
Alzchem : seamlessly builds on strong business performance in 2023 with EBITDA growth of 31.7% in first quarter 2024	04-30	PU
AlzChem : Factsheet (20240430 Factsheet Alzchem EN)	04-28	PU
Young researchers in action: Chemistry Olympiad as a guest at Alzchem	04-25	PU
AlzChem : Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212	03-21	PU
Alzchem Group AG: Alzchem Group AG receives EUR 34.4 million in EU funding	03-15	EQ
Crearene AG and Alzchem Group AG: Successful addition of creatine to dialysis patient treatments	03-11	EQ
Alzchem Group AG: EBITDA increase of 32.4 % to EUR 81.4 million – continuing on the road to success	03-01	EQ
AFR: Alzchem Group AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	02-21	EQ
Alzchem Group AG: Long-Covid: New clinical studies show high efficacy of creatine supplementation	01-11	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases AlzChem Group AG

Equities

ACT

DE000A2YNT30

Press Releases

Filters